Insider · CIK 0001494892

Haluska Frank

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001494892

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-04-29	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+17.3K sh	—	—	164,345
2016-04-29	ARIAD PHARMACEUTICALS INCF Tax Payment	SVP, Clinical R&D, CMO	FTax Payment	−5,634 sh	$7.18	−$40.5K	158,711
2016-04-29	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−17.3K sh	—	—	0
2016-03-21	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−3,575 sh	$6.47	−$23.1K	147,011
2016-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+6,500 sh	—	—	150,586
2016-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−6,500 sh	—	—	0
2016-03-07	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	SVP, Clinical R&D, CMO	AAward	+60K sh	$6.51	+$391K	60,000
2016-03-07	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, Clinical R&D, CMO	AAward	+18K sh	—	—	18,000
2016-03-03	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−10.6K sh	$6.11	−$64.7K	144,086
2016-03-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+19.3K sh	—	—	154,674
2016-03-01	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−19.3K sh	—	—	19,250
2016-03-01	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	SVP, Clinical R&D, CMO	AAward	+38.5K sh	—	—	38,500
2016-02-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+29.3K sh	—	—	151,557
2016-02-01	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−16.1K sh	$4.81	−$77.6K	135,424
2016-02-01	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−29.3K sh	—	—	29,333
2015-09-28	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−5,500 sh	$6.46	−$35.5K	122,224
2015-09-24	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+10K sh	—	—	127,724
2015-09-24	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−10K sh	—	—	10,000
2015-09-24	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	SVP, Clinical R&D, CMO	AAward	+20K sh	—	—	20,000
2015-07-16	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−4,400 sh	$8.54	−$37.6K	117,724
2015-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+8,000 sh	—	—	122,124
2015-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−8,000 sh	—	—	0
2015-04-29	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, Clinical R&D, CMO	AAward	+52K sh	—	—	52,000
2015-03-23	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−3,300 sh	$8.55	−$28.2K	114,124
2015-03-20	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−3,575 sh	$8.85	−$31.6K	111,424
2015-03-20	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+6,000 sh	—	—	117,424
2015-03-20	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−6,000 sh	—	—	0
2015-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+6,500 sh	—	—	114,999
2015-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−6,500 sh	—	—	6,500
2015-02-02	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+29.3K sh	—	—	124,633
2015-02-02	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−16.1K sh	$6.33	−$102K	108,499
2015-02-02	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−29.3K sh	—	—	58,666
2014-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+8,000 sh	—	—	97,907
2014-07-15	ARIAD PHARMACEUTICALS INCF Tax Payment	SVP, Clinical R&D, CMO	FTax Payment	−2,608 sh	$5.57	−$14.5K	95,299
2014-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−8,000 sh	—	—	8,000
2014-03-21	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−2,400 sh	$7.89	−$18.9K	99,196
2014-03-20	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+6,000 sh	—	—	101,596
2014-03-20	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−6,000 sh	—	—	6,000
2014-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+6,500 sh	—	—	97,657
2014-03-19	ARIAD PHARMACEUTICALS INCF Tax Payment	SVP, Clinical R&D, CMO	FTax Payment	−2,061 sh	$8.19	−$16.9K	95,596
2014-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−6,500 sh	—	—	13,000
2014-01-31	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, Clinical R&D, CMO	AAward	+88K sh	—	—	88,000
2013-12-19	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−5,100 sh	$5.14	−$26.2K	91,157
2013-12-18	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+12.8K sh	—	—	96,257
2013-07-18	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−6,400 sh	$19.79	−$127K	83,507
2013-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+16K sh	—	—	89,907
2013-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	SVP, Clinical R&D, CMO	AAward	+32K sh	—	—	32,000
2013-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	−16K sh	—	—	16,000
2013-04-02	ARIAD PHARMACEUTICALS INCS Sale	SVP, Clinical R&D, CMO	SSale	−3,400 sh	$18.04	−$61.3K	73,907
2013-04-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP, Clinical R&D, CMO	MExercise/Conversion	+8,500 sh	—	—	77,307

Recent filings

Accepted (ET)
May 24
ARIAD PHARMACEUTICALS INC0000884731-16-000043
SEC(opens sec.gov)
Mar 224
ARIAD PHARMACEUTICALS INC0000884731-16-000019
SEC(opens sec.gov)
Mar 94
ARIAD PHARMACEUTICALS INC0001628280-16-012503
SEC(opens sec.gov)
Mar 34
ARIAD PHARMACEUTICALS INC0001127602-16-044954
SEC(opens sec.gov)
Feb 34
ARIAD PHARMACEUTICALS INC0001127602-16-039308
SEC(opens sec.gov)
Sep 284
ARIAD PHARMACEUTICALS INC0001127602-15-027731
SEC(opens sec.gov)
Jul 164
ARIAD PHARMACEUTICALS INC0001127602-15-022972
SEC(opens sec.gov)

Companies

Address

C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139